|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
|
|---|---|---|---|---|---|
| Product Sales | |||||
| Royalties | |||||
| Licenses, Milestones and Other | |||||
| Revenues | |||||
| Cost of Sales | |||||
| Gross Profit | |||||
| Operating Expenses | |||||
| Research and Development | |||||
| Selling | |||||
| General and Administrative | |||||
| Total Operating Expenses | |||||
| Operating Profit / (Loss) | |||||
| Other Income | |||||
| Other Expenses | |||||
| Finance Income | |||||
| Finance Expenses | |||||
| Income from Reversals of Impairment Losses / (Impairment Losses) on Financial Assets | |||||
| Share of Loss of Associates accounted for using the Equity Method | |||||
| Income Tax Benefit / (Expenses) | |||||
| Consolidated Net Profit / (Loss) | |||||
| Earnings per Share, Basic and Diluted | |||||
| Earnings per share, basic (in eur per share) | |||||
| Earnings per share, diluted (in eur per share) | |||||
| Shares Used in Computing Earnings per Share, Basic and Diluted | |||||
| Shares used in computing earnings per share, basic (in shares) | |||||
| Shares used in computing earnings per share, diluted (in shares) | |||||
Loading...
